Report Categories
View AllRecent Articles
View All
Can Fangdd Duo Stock Recover Now Duo Q4 Earnings Misses Estimates By 1362.50 20260410 1
OTTR Otter Tail posts 88 Q4 2025 EPS miss with shares dipping 034 after its latest earnings release
Nuveen NCDL Stock Momentum Shift Insight Steady Climb 20260420
TARS Tarsus Pharmaceuticals reports 1467 percent Q4 2025 revenue growth but wider than expected EPS losses push shares 16 percent lower
Textron Inc TXT Valuation Signals Point to Material Undervaluation for Value Investors
Xanadu Quantum Revenue Surges 4x as Photonic Roadmap Accelerates
Red Light Therapy Fortune Experts Explore the Growing Wellness Trend
Nvidia Reports Q1 Fiscal 2027 Net Profit of 583 Billion Tripling YearOverYear Announces 80 Billion Share Buyback
BioVie BIVI Delivers Q1 2026 Beat EPS 070 vs 074 Expected
Berkshire Hathaway Restructures Portfolio with Major Stakes in Delta Air Lines and Alphabet
Wall Street Hits New Peaks Nasdaq and Micron Set Records United Airlines Taps Starlink
Stellantis Refocuses on Jeep Ram Peugeot and Fiat in Major Strategic Overhaul
Ouras Smart Ring Places a LittleKnown Finnish Firm at the Forefront of Wearable Health Tech
Jim Cramer Highlights Stock Picks with Potential 30 Upside in Morning Meeting
Marvell Technology Shares Surge on Accelerating AIDriven Revenue Growth Outlook
Flagstar Bank FLG Q1 2026 Earnings EPS Beats Estimates Shares Rise
CTMX Q1 2026 Earnings Narrower Loss Surprises Analysts
APPF Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction
Tetra Technologies Inc TTI Q1 2026 Earnings Strong Earnings Beat Despite Limited Revenue Disclosure
Advantage Solutions Inc ADV Q1 2026 Earnings Staggering EPS Beat Drives Massive Stock Surge
OXSQG Q1 2026 Earnings EPS Misses Estimates as Notes Decline
Range Capital Acquisition Corp RANG Holds Steady at 1061 as Trading Activity Remains Muted
Fidus Investment Corporation FDUS Edges Lower as Price Tests Key Support Near 1770
GD Culture Group Limited GDC Edges Higher as Penny Stock Holds Key Support
InflaRx IFRX Surges 65 as Stock Tests Key Resistance
Addex Therapeutics ADXN Holds Gains Amid Biotech Sector Momentum
GXAI Q1 2026 Earnings EPS Misses Estimates No Revenue Reported
BKE Q1 2026 Earnings EPS Beats Estimates by 46 Amid Cautious Market Reaction
Healthpeak Properties DOC Q1 2026 Earnings Massive EPS Surprise of 515 Driven by Strong Operations
Kinross Gold KGC Q1 2026 Earnings EPS Falls Short as Cost Pressures Weigh
Cresud Q1 2026 Earnings Strong EPS of 61402 Amid No Revenue Detail Stock Rises 286